Chimeric Antigen Receptor-Engineered (CAR)-T Cell Therapy for Metastatic Prostate Cancer. Tharian L, Verma S, Feinberg D, Parameswaran R, et al. Cancer Lett 2025 Aug 12:217986. doi: 10.1016/j.canlet.2025.217986.

Read + Share

Amedeo Smart

Independent Medical Education

Tharian L, Verma S, Feinberg D, Parameswaran R, et al. Chimeric Antigen Receptor-Engineered (CAR)-T Cell Therapy for Metastatic Prostate Cancer. Cancer Lett 2025 Aug 12:217986. doi: 10.1016/j.canlet.2025.217986.
PMID: 40812718